Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1998 1
1999 1
2003 1
2005 1
2006 2
2007 4
2008 4
2009 4
2010 7
2011 5
2012 7
2013 5
2014 9
2015 8
2016 10
2017 11
2018 8
2019 12
2020 8
2021 7
2022 2
2023 11
2024 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

117 results

Results by year

Filters applied: . Clear all
Page 1
Time-resolved live-cell spectroscopy reveals EphA2 multimeric assembly.
Shi X, Lingerak R, Herting CJ, Ge Y, Kim S, Toth P, Wang W, Brown BP, Meiler J, Sossey-Alaoui K, Buck M, Himanen J, Hambardzumyan D, Nikolov DB, Smith AW, Wang B. Shi X, et al. Science. 2023 Dec;382(6674):1042-1050. doi: 10.1126/science.adg5314. Epub 2023 Nov 16. Science. 2023. PMID: 37972196 Free PMC article.
WDR5 represents a therapeutically exploitable target for cancer stem cells in glioblastoma.
Mitchell K, Sprowls SA, Arora S, Shakya S, Silver DJ, Goins CM, Wallace L, Roversi G, Schafer RE, Kay K, Miller TE, Lauko A, Bassett J, Kashyap A, D'Amato Kass J, Mulkearns-Hubert EE, Johnson S, Alvarado J, Rich JN, Holland EC, Paddison PJ, Patel AP, Stauffer SR, Hubert CG, Lathia JD. Mitchell K, et al. Genes Dev. 2023 Feb 1;37(3-4):86-102. doi: 10.1101/gad.349803.122. Epub 2023 Feb 2. Genes Dev. 2023. PMID: 36732025 Free PMC article.
Piezo1 facilitates optimal T cell activation during tumor challenge.
Abiff M, Alshebremi M, Bonner M, Myers JT, Kim BG, Tomchuck SL, Santin A, Kingsley D, Choi SH, Huang AY. Abiff M, et al. Oncoimmunology. 2023 Nov 22;12(1):2281179. doi: 10.1080/2162402X.2023.2281179. eCollection 2023. Oncoimmunology. 2023. PMID: 38126029 Free PMC article.
The MIF promoter SNP rs755622 is associated with immune activation in glioblastoma.
Alban TJ, Grabowski MM, Otvos B, Bayik D, Wang W, Zalavadia A, Makarov V, Troike K, McGraw M, Rabljenovic A, Lauko A, Neumann C, Roversi G, Waite KA, Cioffi G, Patil N, Tran TT, McCortney K, Steffens A, Diaz CM, Brown JM, Egan KM, Horbinski CM, Barnholtz-Sloan JS, Rajappa P, Vogelbaum MA, Bucala R, Chan TA, Ahluwalia MS, Lathia JD. Alban TJ, et al. JCI Insight. 2023 Jul 10;8(13):e160024. doi: 10.1172/jci.insight.160024. JCI Insight. 2023. PMID: 37252795 Free PMC article.
FGF2: a novel druggable target for glioblastoma?
Jimenez-Pascual A, Mitchell K, Siebzehnrubl FA, Lathia JD. Jimenez-Pascual A, et al. Expert Opin Ther Targets. 2020 Apr;24(4):311-318. doi: 10.1080/14728222.2020.1736558. Epub 2020 Mar 16. Expert Opin Ther Targets. 2020. PMID: 32174197 Free PMC article. Review.
Balancing STAT Activity as a Therapeutic Strategy.
Polak KL, Chernosky NM, Smigiel JM, Tamagno I, Jackson MW. Polak KL, et al. Cancers (Basel). 2019 Nov 3;11(11):1716. doi: 10.3390/cancers11111716. Cancers (Basel). 2019. PMID: 31684144 Free PMC article. Review.
117 results